Management of pulmonary tuberculosis patients in an urban setting in Zambia: a patient's perspective
© Mulenga et al; licensee BioMed Central Ltd. 2010
Received: 23 July 2010
Accepted: 7 December 2010
Published: 7 December 2010
Zambia continues to grapple with a high tuberculosis (TB) burden despite a long running Directly Observed Treatment Short course programme. Understanding issues that affect patient adherence to treatment programme is an important component in implementation of a successful TB control programme. We set out to investigate pulmonary TB patient's attitudes to seek health care, assess the care received from government health care centres based on TB patients' reports, and to seek associations with patient adherence to TB treatment programme.
This was a cross-sectional study of 105 respondents who had been registered as pulmonary TB patients (new and retreatment cases) in Ndola District between January 2006 and July 2007. We administered a structured questionnaire, bearing questions to obtain individual data on socio-demographics, health seeking behaviour, knowledge on TB, reported adherence to TB treatment, and health centre care received during treatment to consenting respondents.
We identified that respondents delayed to seek treatment (68%) even when knowledge of TB symptoms was high (78%) or when they suspected that they had TB (73%). Respondent adherence to taking medication was high (77%) but low adherence to submitting follow-up sputum (47%) was observed in this group. Similarly, caregivers educate their patients more often on the treatment of the disease (98%) and drug taking (100%), than on submitting sputum during treatment (53%) and its importance (54%). Respondent adherence to treatment was significantly associated with respondent's knowledge about the disease and its treatment (p < 0.0001), and with caregiver's adherence to treatment guidelines (p = 0.0027).
There is a need to emphasise the importance of submitting follow-up sputum during patient education and counselling in order to enhance patient adherence and ultimately treatment outcome.
Tuberculosis (TB) continues to be a major health problem in Zambia, despite a long running National Tuberculosis and Leprosy Programme (NTLP). In 2007, the World Health Organization (WHO) estimated the TB burden in Zambia to be at 60,337 cases (all forms of TB) . The TB control efforts have been hampered by the high level of human immunodeficiency virus (HIV) infection, especially in urban settings where prevalence is estimated to be 19.7% . As a result the number of TB and HIV cases threatens to overwhelm the capacity of the general health systems. HIV-TB co-infection rates in Zambia have been estimated at 70% .
Zambia adopted the WHO recommended Directly Observed Treatment Short course (DOTS) strategy as its primary approach in TB control in 1993 and has officially reported 100% DOTS coverage in all nine provinces since 2003 . A good functioning primary health care system is crucial in the implementation of DOTS. In Zambia, the NTLP activities have been integrated into the primary health care services. The decentralisation of TB treatment services has provided for more responsibility at the lower levels of the health care system and in the face of an overwhelming TB case-load, this move has proved to be beneficial to the practical implementation of the programme. Despite the human resource challenges, the use of treatment supporters and community volunteers in the implementation of DOTS has contributed to the improvement in cure rates over the past decade from 67% in 2000 to the global target of 85% by 2006 . The goal of the Zambian NTLP is to prevent and control TB through the provision of quality diagnostic and treatment services for TB and TB/HIV- infected individuals at all levels of the health care delivery system .
Assessing access to quality of healthcare service delivery is complex and multidimensional and will depend on several aspects that are both patient/community-related and/or health systems/service related. Several questions could be considered in this vein, for example, are patients seeking help when they are sick, and when they do seek healthcare, are they getting the appropriate care they require when they need it and ultimately, is this care effective when they get it? Understanding the factors that affect or influence care actions in different settings, will ultimately result in an improvement in healthcare delivery.
Although there are several reports about health seeking behaviour of TB patients and factors related to their delay in seeking health care, compliance to treatment and the role of these factors in treatment outcome, only a few studies describe patient experience in accessing TB care throughout treatment. This study describes and assesses the care received by pulmonary TB patients from government health care centres, and the association with patient adherence to TB treatment based on previous TB patients' reports. The study also alludes to patient's attitude to seek health care for TB.
Study design and population
This was a cross-sectional study of subjects who had been treated for pulmonary TB through the NTLP at government health centres in Ndola, an urbanized city on the Copperbelt Province of Zambia with an estimated population of 374,757 persons , representative of many urban towns along the line of rail in Zambia. At the time of the study, the Ndola District Health Management Team (NDHMT) provided health care services through 26 health centres. All the health centres provided TB treatment and care (treatment centres), but only six were able to perform Acid Fast Bacilli (AFB) smear microscopy (diagnostic centres).
Sampling and sample size
The sampling frame comprised the names of all the smear-positive TB patients, new and retreatment cases, registered in the TB microscopy laboratory registers at the six diagnostic centres between January 2006 and July 2007, as a record of all smear-positive patients undergoing treatment in the 26 treatment centres in that period. Those that had received treatment from private clinics or hospitals and children less than 18 years of age were not included. A sample of 105 respondents was randomly selected from the sampling frame. The sample size was calculated using Epi Info 3.5.1 (Centers for Disease Control and Prevention, Atlanta, GA, USA). Based on pre-test results, we expected a frequency of patient compliance and adherence to treatment of 50%±10%, at a confidence interval of 95%, and non-response level of 10%, and therefore estimated a sample size of 105 as sufficient.
Data collection, management and analysis
Initial contact with the selected respondents was made through the TB focal persons at the health centres. Trained research assistants from the Tropical Diseases Research Centre (TDRC), interviewed consenting participants using a structured questionnaire at their homes. The questionnaire, bore questions to capture individual data on socio-demographics, knowledge on TB, health seeking behaviour, adherence to TB treatment, and reported health centre care during treatment. Most of the questions were closed ended. The questionnaire was pre-tested before use and modifications incorporated in the final version.
The collected data was entered in an MS Access database using Epi Info™3.5.1 (Centers for Disease Control and Prevention, Atlanta, GA, USA), with in-built consistency and range checks. The database was converted to SAS® 9.2 (SAS Institute Inc., Cary, NC, USA) for recoding where necessary and final analyses. Fisher's exact Chi-squared test was used to examine associations of factors. A p ≤ 0.05 was considered significant.
National Guidelines for management of TB
The management of TB patients in Zambia has been standardised under guidelines provided by the NTLP . Except for the seriously ill and identified multidrug resistant (MDR) cases, TB patients are treated on an ambulatory basis. Patients are instructed to pick up medication at TB treatment centres once or twice a week during the intensive phase and once monthly during the continuation phase. The national guidelines stipulate that treatment during the intensive phase should be under direct observation by a trained treatment supporter - usually a relative, while the continuation phase can be self-administered but with monthly supervision from the health centre. Patient education is an important aspect of TB treatment management and is also included in the guidelines to improve cure rates and compliance. Further, as part of patient monitoring and follow up, microscopy is to be repeated at 2, 5 and 8 months. To ensure and improve compliance to sputum follow-up, it is the duty of treatment centres to (1) ensure patients make follow-up visits and submit sputum specimens as required (2) deliver sputum specimens to the nearest diagnostic centre for microscopy and (3) collect microscopy results from diagnostic centres and make available to patients for appropriate care. Patients do not visit diagnostic centres themselves.
The following concepts were used to make analysis.
Respondent treatment adherence
Respondents that reported to have completed eight months of taking medication without interruption, and submitted sputum at least twice post diagnosis - one time point being at eight months - were considered to have adhered to the treatment programme.
Care giver treatment guidelines adherence
Caregivers that were reported by the respondents to have enquired about patient's TB history, provided patient information (on TB disease and its treatment, how to take medication, the requirement to submit follow-up sputum during treatment and the importance of submitting follow-up sputum), and gave the patient an opportunity to ask questions, were considered to have adhered to the TB treatment guidelines.
Respondents that were able to name the correct mode of TB transmission, at least two correct symptoms of TB and knew the importance of treatment completion and sputum submission were considered to be knowledgeable about the disease and its treatment.
Health centre systems access
Health centre delivery systems were considered to be adequate if respondents reported that: the distance to the health centre was less than 30 minutes walk from their home, he/she was commenced on TB treatment not more than 5 days post laboratory diagnosis, and he/she used the same clinic for follow-up treatment and follow-up sputum submission.
Approval for the study protocol was obtained from the Ethics Committee at TDRC. Approval and support were also obtained from the Director of the NDHMT. Consenting respondents were asked to sign an informed consent following an explanation of the study. Interviewers were not part of the health care system. Respondents were assured of anonymity and confidentiality.
Respondent characteristics and health seeking attitudes
Socio-demographic characteristics of the respondents (N = 105)
15 - 24
25 - 34
35 - 44
45 - 54
55 - 64
Distance to clinic
Too far to walk, need to get bus
Previous episode of TB
Respondent treatment adherence
Distribution of respondent and caregiver adherence and health systems access in Ndola, Zambia (N = 105)
A. Respondent adherence to treatment programme
Respondents that complied and adhered to treatment programme
1. Respondents that completed medication without stopping at any point
2. Respondents that submitted sputum as required
B. Caregiver adherence to treatment guideline
Respondents whose caregivers adhered to treatment guidelines
1. Respondents whose caregivers enquired about their TB history
2. Respondents whose caregivers educated them on:
the disease and its treatment
how to take medication
requirement of submitting follow-up sputum
the importance of follow-up sputum submission
3. Respondents who were given an opportunity to ask questions
C. Respondents' knowledge on the disease
Respondents that demonstrated knowledge on the disease and its treatment
1. Respondents that gave the correct mode of TB transmission
2. Respondents that gave at least two correct symptoms of TB
3. Respondents that knew the importance of treatment completion
4. Respondents that knew the importance of follow-up sputum submission
D. Health centre systems access
Respondents that reported adequate healthcare systems access
1. Respondents who reported the distance to the health centre as being too far
2. Respondents who reported commencing treatment within a week of diagnosis
3. Respondents who reported using the same clinic for treatment and sputum submission
Care giver treatment guidelines adherence
The majority of respondents (84%) confirmed that they were asked if they had suffered from TB previously before commencement of TB treatment. To the questions enquiring whether the health-worker explained how to take the medication and whether the instructions were clear, nearly all responded favourably. When asked if the health worker informed them at the initiation of treatment that they would have to submit more sputum samples during treatment, 53% said yes; all of whom reported that the health centre staff explained to them the importance of submitting follow-up sputum specimens. Forty-nine (47%) respondents reported that they were given an opportunity to ask questions for clarifications. Table 2 (B) shows performance of caregivers' adherence to treatment guidelines.
Respondent knowledge and awareness of TB
When asked to name some symptoms of TB, a significant proportion of the respondents (78%) was able to mention at least two symptoms, with cough being the most identified symptom (89%). A considerable number (69%) of the respondents correctly knew the mode of transmission of TB, however, 13% incorrectly cited using the same utensils. Knowledge of the importance of completing medication for eight months was high (89%) but knowledge for the importance of submitting follow-up sputum was lower (55%). Ninety-one percent of the respondents reported that they knew they were cured of their last TB episode, but when asked how they knew they were cured, reasons ranged from feeling better (80%), the fact that they took medication for eight months (15%), to that laboratory results were negative (4%). Table 2 (C) shows performance of respondents with regards to knowledge and awareness of TB. Most respondents (71%) did not suspect that they had TB despite the large number (85%) naming cough as one of the symptoms they experienced.
Healthcare systems access
TB treatment centres appeared relatively close to the respondents' homes: 80% lived within 30 minutes walk, 18% lived within an hour's walk and 2% said it was too far to walk and needed to take a bus. Respondents were also asked how long after being diagnosed with TB it took before starting medication; all the respondents reported that they were started on treatment within one week of diagnosis, with 86% starting within two days.
When respondents were asked if they had used the same clinic for their follow-up visits and drug collection throughout treatment, affirmative responses were 87%. Respondents were further asked if they had submitted their follow-up sputum samples to the same clinic they went for reviews and collected drugs from, and 73% said yes. Table 2 (D) shows performance of health centres with regards to access as reported by the respondents.
Factors significantly associated with respondent adherence
Respondent adherence associations to Caregiver adherence, Respondent knowledge and Health system accessibility (N = 105).
Respondent adherence to treatment programme
Did not adhere
A. Caregiver adherence to treatment guidelines
Did not adhere to guidelines
Adhered to guidelines
B. Respondents' knowledge on TB
C. Health centre systems access
Not good/not efficient
Further analyses showed that caregivers explaining the importance and schedule of follow-up sputum submission was significantly associated with respondents' adherence to sputum submission as required (p < 0.0001), but not with respondents' completing medication for eight months (p = 0.0562).
The success of a national TB program is multi-faceted and complex. Community awareness; patients' adherence to treatment; patient access to quality of care through competent healthcare staff who are able to provide quality of care through prompt diagnosis and referral, prescription of correct treatment regimens and treatment follow-up; and accessible TB services, are important components of a successful TB program.
Consequently, it is important that people in communities are aware and able to suspect TB in persons who show signs and symptoms suggestive of the disease, such as prolonged cough, persistent fevers, and weight loss. Maybe not surprising, as previous TB patients our respondents showed a good level of knowledge on the symptoms and modes of transmission of TB, attributable to caregiver education during treatment. However, our study revealed vast differences in knowledge regarding the importance of treatment completion compared to knowledge of the importance of follow-up sputum submission; whereas, nearly 90% knew the importance of treatment completion, only 57% knew the importance of the latter, reflective of the low importance given to the relevance of education on this issue. Similarly, other studies have shown that most TB patients know the importance of treatment completion [7–9]. According to our conceptual framework, overall knowledge of the disease was low, mainly due to the low knowledge gap in the role of sputum microscopy in TB treatment by the respondents.
Despite the high knowledge levels of TB symptoms shown in our study, most respondents not only, reported not to have suspected they had TB, but also reported that they delayed seeking care (even when they suspected they had TB). Whereas it is possible that respondents were truly unaware of TB symptoms prior to TB treatment, several other studies have shown that there are various reasons why patients delay seeking care at a health centres. Loss of income, health centre systems or staff attitudes, stigma of the HIV association, severity of disease, lifestyle, for example, alcohol abuse, are among the many explanations [9–13]. The most common reasons in our study, 'I was thinking the symptoms will go away' or 'I did not think it was serious' also appear to be common in different settings [8, 12]. This may be reflective of the commonly practiced self-treatment, which may ameliorate initial symptoms thus temporarily masking the severity of disease and consequently 'buy them time' to continue with their daily income generating endeavours. Only 17% of our study population were in formal employment suggesting that for most respondents an income was dependent on their daily efforts and therefore may not afford the time at the health centre. Further, the period of the study, were the early days of scaling up of free antiretroviral therapy in Zambia and so people may still have been feeling helpless against HIV infection.
Our results showed that only 47% of respondents reported to have submitted follow-up sputum at least twice post diagnosis and that 67% reported submitting follow-up sputum at the end of treatment. These results may be cause for concern because sputum re-examination at the end of the patient's treatment is a much stronger indicator of treatment success than 'treatment completion. Further, data in one of our studies in this population, has shown that among subjects who experienced another episode of TB within one year of completing treatment, there were more who harboured the same M. tuberculosis strain as that of the previous episode (relapses/treatment failures) than those that had a different strain (re-infection) (unpublished data). Furthermore, our study showed a high proportion of respondents taking of drugs for the complete period of treatment (89%) with a notable proportion (22%) reporting stopping medication at some point during treatment. Over half (55%) cited that they stopped because they were feeling better, similar to many other studies [14, 8, 15].
The role of the health worker on patient compliance has been described many times [16–18]. Patient counselling and good communication [19, 20] can improve patient compliance. Our study showed high levels of patient satisfaction when it came to health provider explanation regarding medication. However, we did not see the same positive response with regards to health provider explanation on the role of follow-up sputum submission. Only about half of the respondents reported that they were informed about the requirement (53%) and importance (54%) of submitting follow-up sputum. In fact, these two parameters were shown to be significantly associated with respondent adherence (p < 0.0001 for both). A study in Egypt demonstrated that adherence to recommended sputum smear microscopy schedule was significantly associated with treatment success . Our study also showed that respondent adherence to treatment was significantly associated with respondent's knowledge about the disease and its treatment (p < 0.0001) in contrast to other studies [22, 8].
Moreover, caregivers' communication skills fell short on account of dialogue, giving the patient a chance to ask questions, an important aspect in patient management that ensures patient understanding of disease and treatment. The effects of non-dialogue counselling were demonstrated in a study in Madagascar where reported lack of opportunity to ask questions by patient was significantly associated with non-adherence .
Other features of the health system, like distance, convenience of TB services (microscopy, antiretroviral treatment services), how long it takes to see the clinician, prompt diagnosis and referral of TB patients presenting with TB-related symptoms at primary health care facilities, may have an effect on patient access to healthcare. Distance to the health centre for this population was not an issue. Delays in the commencement of treatment have been documented in some settings , our study, however, showed that all the respondents were given medication within one week of diagnosis, with 84% commencing treatment within two days post laboratory diagnosis. The NTLP in Zambia has given full responsibility of sputum transportation plus obtaining and communicating results for each patient, to the treatment centres. This not only reduces on the number of patients, who remain undiagnosed following initial health centre visit, but also removes the inconvenience and added travel costs from the patients. The majority of our respondents reported that they used the same treatment centre for sputum submission. Our results indicate that facility-service related factors may not be the main issue in patients' access to TB care in Ndola, unlike the study from KwaZulu-Natal where systems failure was reported as contributing to the ineffectiveness of the National Tuberculosis Program .
Admittedly, because this study asked questions about past events, participants' recall may have biased our results. In addition, since the interview was anonymous to ensure complete confidentiality, we were not able to go back to the patient's data files to verify the self-reported data. Nevertheless, the implied cure rate for this sample population is comparable to the average cure rate data for the same period from Ndola. Another limitation for this study is that we did not establish from the respondents how long it took for laboratory results to be available for diagnosis, a factor that could well contribute to delay in TB patient care. However, enquiries from TB focal persons indicated a turnaround time for lab results ranging from the same day to a week. Further, our study did not include all components of TB treatment and care in the National Guidelines and consequently, other components that contribute to this package have not been discussed. Lastly, it is well known that respondents usually consider the interviewer to represent authority or the healthcare system and therefore tend to bias their answers in the way they expect they should to please the interviewer. Consequently, although the study made efforts to use researchers from outside the respondents' healthcare system, it is difficult to completely remove this perception in communities.
In conclusion, TB treatment systems appear to be well in place in NDHMT. However, taken together, these results suggest that closer monitoring systems on guidelines adherence at health centres may need strengthening and more patient counselling on treatment of disease and importance of sputum submission may improve cure rates.
This study was supported by funds from a grant of the Belgian Directorate-General for Development Cooperation (DGDC) from which Chanda Mulenga is a scholarship recipient, and the Damien Action, Brussels, Belgium. We would like to thank, the two research assistants from TDRC, Joyce W Mulenga and Victoria Luo for their hard work in questionnaire administration, the NDHMT, and the TB Focal Persons in the participating health centres for the assistance in implementation of the study. We also acknowledge Webster Kasongo for his useful contributions to the manuscript.
- World Health Organization: Global Tuberculosis Control WHO Report. WHO/HTM/TB/2009.411. 2009, Geneva, Switzerland; WHOGoogle Scholar
- Central Statistical Office (CSO), Ministry of Health (MOH), Tropical Diseases Research Centre (TDRC), University of Zambia UNZA), and Macro International Inc: Zambia Demographic and Health Survey 2007. 2009, Calverton, Maryland, USA; CSO and Macro International IncGoogle Scholar
- World Health Organization: "TB Country Profile, Zambia". [Accessed on 4 December 2010], [http://www.who.int/countries/zmb/en/]
- Ministry of Health: National TB Strategic Plan 2006-2011. The National TB and Leprosy Control Programme. Ministry of Health, Lusaka, Zambia
- Central Statistics Office: Summary Report, Zambia 2000 Census of Population and Housing. 2003, Central Statistics Office, Lusaka, ZambiaGoogle Scholar
- Ministry of Health: Tuberculosis and TB/HIV Manual, Third Edition. The National TB and Leprosy Control Programme. Ministry of Health, Lusaka, Zambia
- Kaona FA, Tuba M, Siziya S, Sikaona L: An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004, 29: 4:68-Google Scholar
- Liam CK, Lim KH, Wong CM, Tang BG: Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis. 1999, 3 (4): 300-309.PubMedGoogle Scholar
- Kilale AM, Mushi AK, Lema LA, Kunda J, Makasi CE, Mwaseba D, Range NS, Mfinanga GS: Perceptions of tuberculosis and treatment seeking behaviour in Ilala and Kinondoni Municipalities in Tanzania. Tanzan J Health Res. 2008, 10 (2): 89-94.View ArticlePubMedGoogle Scholar
- Storla DG, Yimer S, Bjune GA: A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008, 8: 15-10.1186/1471-2458-8-15.View ArticlePubMedPubMed CentralGoogle Scholar
- Needham DM, Foster SD, Tomlinson G, Godfrey-Faussett P: Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health. 2001, 6 (4): 256-259. 10.1046/j.1365-3156.2001.00709.x.View ArticlePubMedGoogle Scholar
- Demissie M, Lindtjorn B, Berhane Y: Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia. BMC Public Health. 2002, 2: 23-10.1186/1471-2458-2-23.View ArticlePubMedPubMed CentralGoogle Scholar
- Cramm JM, Finkenflügel HJ, Møller V, Nieboer AP: TB treatment initiation and adherence in a South African community influenced more by perceptions than by knowledge of tuberculosis. BMC Public Health. 2010, 10: 72-10.1186/1471-2458-10-72.View ArticlePubMedPubMed CentralGoogle Scholar
- Suri A, Gan K, Carpenter S: Voices from the field: perspectives from community health workers on health care delivery in rural KwaZulu-Natal, South Africa. J Infect Dis. 2007, 196 (Suppl 3): S505-11. 10.1086/521122.View ArticlePubMedGoogle Scholar
- Jaiswal A, Singh V, Ogden JA, Porter JD, Sharma PP, Sarin R, Arora VK, Jain RC: Adherence to tuberculosis treatment: lessons from the urban setting of Delhi, India. Trop Med Int Health. 2003, 8 (7): 625-633. 10.1046/j.1365-3156.2003.01061.x.View ArticlePubMedGoogle Scholar
- Comolet TM, Rakotomalala R, Rajaonarioa H: Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis. 1998, 2 (11): 891-897.PubMedGoogle Scholar
- Bultman DC, Svarstad BL: Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns. 2000, 40 (2): 173-185. 10.1016/S0738-3991(99)00083-X.View ArticlePubMedGoogle Scholar
- Brus H, van de Laar M, Taal E, Rasker J, Wiegman O: Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Couns. 1999, 36 (1): 57-64. 10.1016/S0738-3991(98)00087-1.View ArticlePubMedGoogle Scholar
- Liefooghe R, Suetens C, Meulemans H, Moran MB, De Muynck A: A randomised trial of the impact of counselling on treatment adherence of tuberculosis patients in Sialkot, Pakistan. Int J Tuberc Lung Dis. 1999, 3 (12): 1073-1080.PubMedGoogle Scholar
- Mishra P, Hansen EH, Sabroe S, Kafle KK: Adherence is associated with the quality of professional-patient interaction in Directly Observed Treatment Short-course, DOTS. Patient Educ Couns. 2006, 63 (1-2): 29-37. 10.1016/j.pec.2005.08.006.View ArticlePubMedGoogle Scholar
- Elmahalli AA, Abdel-Aziz BF: Assessment of the implementation of DOTS strategy in two chest facilities in Alexandria, Egypt. East Mediterr Health J. 2007, 13 (5): 1085-1097.PubMedGoogle Scholar
- Lertmaharit S, Kamol-Ratankul P, Sawert H, Jittimanee S, Wangmanee S: Factors Associated with Compliance among Tuberculosis Patients in Thailand. J Med Assoc Thai. 2005, 88 (Suppl 4): S149-156.PubMedGoogle Scholar
- Maher D, Hausler HP, Raviglione MC, Kaleeba N, Aisu T, Fourie B, Nunn P: Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. Int J Tuberc Lung Dis. 1997, 1 (3): 276-83.PubMedGoogle Scholar
- Loveday M, Thomson L, Chopra M, Ndlela Z: A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance. Int J Tuberc Lung Dis. 2008, 12 (9): 1042-1047.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/10/756/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.